Skip to content
PubMed This is a summary of 101 peer-reviewed journal articles Updated
Medical Genetics

Trisomy 18: A Patient Guide

At a Glance

Trisomy 18 is a genetic condition with full, mosaic, and partial forms that can affect several organs. Care decisions—including surgery, intensive care, or comfort-focused support—should be individualized with the family and medical team.

Disclaimer: This resource supports—but does not replace—individualized advice from your genetics, maternal-fetal medicine, neonatology, cardiology, feeding, and palliative-care teams.

Trisomy 18, also known as Edwards syndrome, is a genetic condition caused by the presence of a third copy of chromosome 18 in some or all of the body’s cells [1][2][3]. This extra genetic material changes the “instructions” for how a child develops, typically leading to challenges that involve multiple organ systems, including the heart, lungs, and brain [4][5][6][1]. While it is a serious condition with high medical complexity, our understanding of Trisomy 18 has transformed in recent years, moving away from old labels toward a focus on the unique health and potential of every individual child [7][8][9][8].

The way Trisomy 18 behaves depends significantly on the specific genetic subtype identified. Most children have the “full” (or “free”) form, where the extra chromosome is in nearly all cells tested, while others have “mosaic” or “partial” forms where only some cells or segments of the chromosome are affected [1][2][3][10][6]. Because these subtypes can lead to very different clinical outcomes and survival patterns, knowing your child’s exact diagnosis is a critical first step in understanding their needs [11][11]. Regardless of the subtype, each child’s journey is shaped by their specific physical findings rather than the genetic label alone [12][8][13][12].

Modern medical care for Trisomy 18 is rooted in shared decision-making, a collaborative approach where you and your medical team work as partners [14][15][14]. Decisions about life-prolonging treatments, such as heart surgery or intensive care, are now made on a case-by-case basis by weighing the potential benefits against the burdens for your child [12][13][8][13]. This individualized approach recognizes that while the condition is life-limiting for many, some children survive for years and reach meaningful developmental milestones, such as smiling, interacting with family, and showing clear preferences [8][12][14][15][16].

As you navigate these choices, specialized support is available to help your family maintain the best possible quality of life. Palliative care is an essential resource that can be integrated into your child’s care at any time—it is not a replacement for medical treatment, but an extra layer of support that works alongside it [9][7][8][9]. Whether you choose a path focused on intensive interventions or one centered on comfort at home, the goal is to ensure your child is supported, your family is heard, and every decision is made with respect for your child’s unique life [8][13][17][9][7][7].

Common questions in this guide

What is Trisomy 18, also called Edwards syndrome?
Trisomy 18, or Edwards syndrome, is a genetic condition caused by an extra copy of chromosome 18 in some or all of the body's cells. The extra genetic material can affect several organ systems, including the heart, lungs, and brain.
What are the full, mosaic, and partial forms of Trisomy 18?
In full, or free, Trisomy 18, the extra chromosome is present in nearly all cells tested. In mosaic Trisomy 18, only some cells are affected, while partial Trisomy 18 involves an extra segment of chromosome 18; these forms can have different health needs and outcomes.
How are treatment decisions made for a child with Trisomy 18?
Treatment decisions are made individually by considering your child's current health findings, the likely benefits, and the burdens of each option rather than relying on the genetic diagnosis alone. Depending on the situation, the team may discuss heart surgery, intensive care, or other medical and surgical treatments.
Can a child with Trisomy 18 live for years?
Trisomy 18 is life-limiting for many children, but outcomes vary by genetic form and individual health findings. Some children survive for years and may reach meaningful developmental milestones such as smiling, interacting with family, and showing clear preferences.
What does palliative care do for a child with Trisomy 18?
Palliative care adds support for your child's and family's quality of life and care goals while other treatments continue. It can be integrated at any time and is not a replacement for medical treatment.
What is a time-limited trial of intensive care?
A time-limited trial is an agreed period of intensive treatment with specific goals for your child's response and well-being. The family and medical team then review what happened and decide whether to continue, change, or stop that approach.

Get notified when new evidence is published on Trisomy 18 syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    [Mosaic trisomy 18. Series of cases].

    Cammarata-Scalisi F, Lacruz-Rengel MA, Araque D, et al.

    Archivos argentinos de pediatria 2017; (115(3)):e183-e186 doi:10.5546/aap.2017.e183.

    PMID: 28504507
  2. 2

    A visual tool inclusive of fetal ultrasound and autopsy findings to reach a balanced approach to counseling on trisomy 18 in early second trimester.

    Triunfo S, Bonollo M, Gaffuri P, et al.

    Archives of gynecology and obstetrics 2021; (304(5)):1115-1125 doi:10.1007/s00404-021-06130-7.

    PMID: 34159403
  3. 3

    A Case of a Derivative Chromosome: der(Y)t(Y;18)Pat with Congenital Abnormalities.

    Huang S, Xia Y, Ding H, et al.

    Fetal and pediatric pathology 2021; (40(3)):256-261 doi:10.1080/15513815.2019.1695297.

    PMID: 31805817
  4. 4

    Congenital anomalies associated with trisomy 18 or trisomy 13: A registry-based study in 16 European countries, 2000-2011.

    Springett A, Wellesley D, Greenlees R, et al.

    American journal of medical genetics. Part A 2015; (167A(12)):3062-9 doi:10.1002/ajmg.a.37355.

    PMID: 26347425
  5. 5

    An analysis of cardiac defects and surgical interventions in 84 cases with full trisomy 18.

    Bruns DA, Martinez A

    American journal of medical genetics. Part A 2016; (170A(2)):337-343 doi:10.1002/ajmg.a.37427.

    PMID: 26453443
  6. 6

    Wilms Tumor in Child With Trisomy 18 and Horseshoe Kidney.

    Chen E, Hackney L, VanHeyst K, Miyasaka EA

    Journal of pediatric hematology/oncology 2023; (45(8)):e1018-e1022 doi:10.1097/MPH.0000000000002756.

    PMID: 37749779
  7. 7

    Trisomy 18-when the diagnosis is compatible with life.

    Silva C, Ferreira MC, Saraiva J, Cancelinha C

    European journal of pediatrics 2022; (181(7)):2809-2819 doi:10.1007/s00431-022-04477-w.

    PMID: 35522316
  8. 8

    Guidance for Caring for Infants and Children With Trisomy 13 and Trisomy 18: Clinical Report.

    Pyle AK, George TN, Cummings JJ, et al.

    Pediatrics 2025; (156(2)) doi:10.1542/peds.2025-072719.

    PMID: 40685149
  9. 9

    Cardiac Interventions for Patients With Trisomy 13 and Trisomy 18: Experience, Ethical Issues, Communication, and the Case for Individualized Family-Centered Care.

    Cleary JP, Janvier A, Farlow B, et al.

    World journal for pediatric & congenital heart surgery 2022; (13(1)):72-76 doi:10.1177/21501351211044132.

    PMID: 34919485
  10. 10

    Phenotypic Spectrum of Trisomy 18 Mosaicism: a New Patient and Literature Review.

    Sun W, Wang L, Liu T, et al.

    Clinical laboratory 2023; (69(3)) doi:10.7754/Clin.Lab.2022.220610.

    PMID: 36912299
  11. 11

    Long-Term Survival Among Children With Trisomy 13 and Trisomy 18 by Cytogenetic Status.

    Ludorf KL, Benjamin RH, Shumate CJ, et al.

    JAMA network open 2025; (8(9)):e2529885 doi:10.1001/jamanetworkopen.2025.29885.

    PMID: 40920381
  12. 12

    The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Recommendation for the care of children with trisomy 13 or trisomy 18 and a congenital heart defect.

    St Louis JD, Bhat A, Carey JC, et al.

    The Journal of thoracic and cardiovascular surgery 2024; (167(5)):1519-1532 doi:10.1016/j.jtcvs.2023.11.054.

    PMID: 38284966
  13. 13

    Structured Framework for Multidisciplinary Parent Counseling and Medical Interventions for Fetuses and Infants with Trisomy 13 or Trisomy 18.

    Kim AJH, Marshall M, Gievers L, et al.

    American journal of perinatology 2024; (41(S 01)):e2666-e2673 doi:10.1055/s-0043-1772748.

    PMID: 37619598
  14. 14

    Shared decision making and the pathways approach in the prenatal and postnatal management of the trisomy 13 and trisomy 18 syndromes.

    Andrews SE, Downey AG, Showalter DS, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2016; (172(3)):257-63 doi:10.1002/ajmg.c.31524.

    PMID: 27557275
  15. 15

    Using Patient-Centered Care After a Prenatal Diagnosis of Trisomy 18 or Trisomy 13: A Review.

    Haug S, Goldstein M, Cummins D, et al.

    JAMA pediatrics 2017; (171(4)):382-387 doi:10.1001/jamapediatrics.2016.4798.

    PMID: 28192554
  16. 16

    Developmental status of 22 children with trisomy 18 and eight children with trisomy 13: implications and recommendations.

    Bruns DA

    American journal of medical genetics. Part A 2015; (167A(8)):1807-15 doi:10.1002/ajmg.a.37102.

    PMID: 25847310
  17. 17

    Transitions in Care for Infants with Trisomy 13 or 18.

    Patterson J, Taylor G, Smith M, et al.

    American journal of perinatology 2017; (34(9)):887-894 doi:10.1055/s-0037-1600912.

    PMID: 28301894

This page is for informational purposes only and does not constitute medical advice. Your child's genetics, maternal-fetal medicine, neonatology, cardiology, feeding, and palliative-care teams can help interpret the diagnosis and discuss individualized options.